Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Acyclic Nucleoside Analogs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105732631A reveals efficient N9 vinyl purine synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with high yield and scalability.
Patent CN107501267B reveals Pd-catalyzed asymmetric allylic amination for high-purity nucleoside intermediates. Enables cost reduction and supply chain reliability.